1
|
Panelli S, D'Auria E, Papaleo S, Alvaro A, Bandi C, Comandatore F, Zuccotti G. Biotics in pediatrics: a short overview. Minerva Pediatr (Torino) 2022; 74:682-687. [PMID: 35822582 DOI: 10.23736/s2724-5276.22.06989-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
The aim of this review was to provide a general overview to the topic of this special issue. In this study the available categories of biotics were defined (i.e., probiotics, prebiotics, postobiotics and synbiotics) as first actors of therapies that target the gut flora, with the aim to modify it in a specific direction, generally with the goal of controlling inflammatory phenomena. The points that must be considered when evaluating the results of these interventions, and, specifically, the changes in gut microbiota following the assumption of biotics were analyzed. This context typically represented the one of clinical trials aimed at inducing or maintaining remission in pediatric autoimmune inflammatory diseases, that often yield conflicting results. We finally attempted to draft possible research developments for the next years.
Collapse
Affiliation(s)
- Simona Panelli
- Department of Biomedical and Clinical Sciences, "Romeo ed Enrica Invernizzi" Pediatric Clinical Research Center, University of Milan, Milan, Italy -
| | - Enza D'Auria
- Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy
| | - Stella Papaleo
- Department of Biomedical and Clinical Sciences, "Romeo ed Enrica Invernizzi" Pediatric Clinical Research Center, University of Milan, Milan, Italy
| | - Alessandro Alvaro
- Department of Biosciences, "Romeo ed Enrica Invernizzi" Pediatric Clinical Research Center, University of Milan, Milan, Italy
| | - Claudio Bandi
- Department of Biosciences, "Romeo ed Enrica Invernizzi" Pediatric Clinical Research Center, University of Milan, Milan, Italy
| | - Francesco Comandatore
- Department of Biomedical and Clinical Sciences, "Romeo ed Enrica Invernizzi" Pediatric Clinical Research Center, University of Milan, Milan, Italy
| | - Gianvincenzo Zuccotti
- Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy
| |
Collapse
|
2
|
Pistone D, Meroni G, Panelli S, D’Auria E, Acunzo M, Pasala AR, Zuccotti GV, Bandi C, Drago L. A Journey on the Skin Microbiome: Pitfalls and Opportunities. Int J Mol Sci 2021; 22:9846. [PMID: 34576010 PMCID: PMC8469928 DOI: 10.3390/ijms22189846] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2021] [Revised: 09/07/2021] [Accepted: 09/08/2021] [Indexed: 12/22/2022] Open
Abstract
The human skin microbiota is essential for maintaining homeostasis and ensuring barrier functions. Over the years, the characterization of its composition and taxonomic diversity has reached outstanding goals, with more than 10 million bacterial genes collected and cataloged. Nevertheless, the study of the skin microbiota presents specific challenges that need to be addressed in study design. Benchmarking procedures and reproducible and robust analysis workflows for increasing comparability among studies are required. For various reasons and because of specific technical problems, these issues have been investigated in gut microbiota studies, but they have been largely overlooked for skin microbiota. After a short description of the skin microbiota, the review tackles methodological aspects and their pitfalls, covering NGS approaches and high throughput culture-based techniques. Recent insights into the "core" and "transient" types of skin microbiota and how the manipulation of these communities can prevent or combat skin diseases are also covered. Finally, this review includes an overview of the main dermatological diseases, the changes in the microbiota composition associated with them, and the recommended skin sampling procedures. The last section focuses on topical and oral probiotics to improve and maintain skin health, considering their possible applications for skin diseases.
Collapse
Affiliation(s)
- Dario Pistone
- Pediatric Clinical Research Center “Invernizzi”, Department of Biomedical and Clinical Sciences “L. Sacco”, University of Milan, 20157 Milan, Italy; (S.P.); (A.R.P.); (G.V.Z.)
- Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy;
| | - Gabriele Meroni
- Department of Biomedical Surgical and Dental Sciences-One Health Unit, University of Milan, 20133 Milan, Italy;
| | - Simona Panelli
- Pediatric Clinical Research Center “Invernizzi”, Department of Biomedical and Clinical Sciences “L. Sacco”, University of Milan, 20157 Milan, Italy; (S.P.); (A.R.P.); (G.V.Z.)
| | - Enza D’Auria
- Department of Pediatrics, Children’s Hospital Vittore Buzzi, University of Milan, 20154 Milan, Italy; (E.D.); (M.A.)
| | - Miriam Acunzo
- Department of Pediatrics, Children’s Hospital Vittore Buzzi, University of Milan, 20154 Milan, Italy; (E.D.); (M.A.)
| | - Ajay Ratan Pasala
- Pediatric Clinical Research Center “Invernizzi”, Department of Biomedical and Clinical Sciences “L. Sacco”, University of Milan, 20157 Milan, Italy; (S.P.); (A.R.P.); (G.V.Z.)
| | - Gian Vincenzo Zuccotti
- Pediatric Clinical Research Center “Invernizzi”, Department of Biomedical and Clinical Sciences “L. Sacco”, University of Milan, 20157 Milan, Italy; (S.P.); (A.R.P.); (G.V.Z.)
- Department of Pediatrics, Children’s Hospital Vittore Buzzi, University of Milan, 20154 Milan, Italy; (E.D.); (M.A.)
| | - Claudio Bandi
- Pediatric Clinical Research Center “Invernizzi”, Department of Biosciences, University of Milan, 20133 Milan, Italy;
| | - Lorenzo Drago
- Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy;
| |
Collapse
|
3
|
Sainz T, Delgado J, Mendez‐Echevarría A, Santiago B, Lopez‐Varela E, Aguilera‐Alonso D, Saavedra‐Lozano J, Rodríguez‐Fernández R, Holguín Á, Navarro ML, Muñoz‐Fernández MÁ, Rivero‐Calle I, Solana MJ, López‐Herce J, Calvo C. The clinical relevance of the microbiome when managing paediatric infectious diseases-Narrative review. Acta Paediatr 2021; 110:441-449. [PMID: 32961592 DOI: 10.1111/apa.15578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 08/18/2020] [Accepted: 09/15/2020] [Indexed: 11/28/2022]
Abstract
In recent years, the field of infectious diseases has been hit by the overwhelming amount of information generated while the human microbiome is being disentangled. Based on the interaction between the microbiota and the immune system, the implications regarding infectious diseases are probably major and remain a challenge. AIMS This review was conceived as a comprehensive tool to provide an overview of the available evidence regarding the influence of the microbiome on infectious diseases in children. METHODS We present the main findings aroused from microbiome research in prevention, diagnosis and treatment of infectious disease under a paediatric perspective, to inform clinicians of the potential relevance of microbiome-related knowledge for translation to clinical practice. RESULTS AND CONCLUSION The evidence shown in this review highlights the numerous research gaps ahead and supports the need to move forward to integrating the so-called microbiome thinking into our routine clinical practice.
Collapse
Affiliation(s)
- Talía Sainz
- Hospital La Paz and La Paz Research Intitute (IdiPAZ) Madrid Spain
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
| | - Jaime Delgado
- Hospital La Paz and La Paz Research Intitute (IdiPAZ) Madrid Spain
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
| | - Ana Mendez‐Echevarría
- Hospital La Paz and La Paz Research Intitute (IdiPAZ) Madrid Spain
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
| | - Begoña Santiago
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
- Hospital General Universitario Gregorio Marañón and Research Institute IISGM Madrid Spain
| | - Elisa Lopez‐Varela
- ISGlobal, Barcelona Centre for International Health ResearchHospital Clinic ‐ Universitat de Barcelona Barcelona Spain
| | - David Aguilera‐Alonso
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
- Hospital General Universitario Gregorio Marañón and Research Institute IISGM Madrid Spain
| | - Jesús Saavedra‐Lozano
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
- Hospital General Universitario Gregorio Marañón and Research Institute IISGM Madrid Spain
| | - Rosa Rodríguez‐Fernández
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
- Hospital General Universitario Gregorio Marañón and Research Institute IISGM Madrid Spain
| | - África Holguín
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
- Ramón y Cajal Research Institute (IRyCIS)‐CIBERESP in Hospital Ramón y Cajal Madrid Spain
| | - Marisa L. Navarro
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
- Hospital General Universitario Gregorio Marañón and Research Institute IISGM Madrid Spain
| | - María Ángeles Muñoz‐Fernández
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
- Hospital General Universitario Gregorio Marañón and Research Institute IISGM Madrid Spain
| | - Irene Rivero‐Calle
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
- Hospital Clínico Universitario de Santiago‐CHUS and Health Research Institute of Santiago de Compostela (IDIS) Santiago de Compostela Spain
| | - María José Solana
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
- Hospital General Universitario Gregorio Marañón and Research Institute IISGM Madrid Spain
| | - Jesús López‐Herce
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
- Hospital General Universitario Gregorio Marañón and Research Institute IISGM Madrid Spain
| | - Cristina Calvo
- Hospital La Paz and La Paz Research Intitute (IdiPAZ) Madrid Spain
- The Traslational Research Network of Pediatric Infectious Diseases (RITIP) Madrid Spain
| |
Collapse
|
4
|
Cumpanas AA, Bratu OG, Bardan RT, Ferician OC, Cumpanas AD, Horhat FG, Licker M, Pricop C, Cretu OM. Urinary Microbiota-Are We Ready for Prime Time? A Literature Review of Study Methods' Critical Steps in Avoiding Contamination and Minimizing Biased Results. Diagnostics (Basel) 2020; 10:diagnostics10060343. [PMID: 32471022 PMCID: PMC7345871 DOI: 10.3390/diagnostics10060343] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Revised: 05/20/2020] [Accepted: 05/25/2020] [Indexed: 12/11/2022] Open
Abstract
Within the last few years, there have been an increased number of clinical studies involving urinary microbiota. Low-biomass microbiome sequencing (e.g., urine, lung, placenta, blood) is easily biased by contamination or cross-contamination. So far, a few critical steps, from sampling urine to processing and analyzing, have been described (e.g., urine collection modality, sample volume size, snap freezing, negative controls usage, laboratory risks for contamination assessment, contamination of negative results reporting, exploration and discussion of the impact of contamination for the final results, etc.) We performed a literature search (Pubmed, Scopus and Embase) and reviewed the published articles related to urinary microbiome, evaluating how the aforementioned critical steps to obtain unbiased, reliable results have been taken or have been reported. We identified different urinary microbiome evaluation protocols, with non-homogenous reporting systems, which can make gathering results into consistent data for similar topics difficult and further burden the already so complex emerging field of urinary microbiome. We concluded that to ease the progress in this field, a joint approach from researchers, authors and publishers would be necessary in order to create mandatory reporting systems which would allow to recognize pitfalls and avoid compromising a promising field of research.
Collapse
Affiliation(s)
- Alin Adrian Cumpanas
- Department of Urology, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (A.A.C.); (R.T.B.); (O.C.F.)
| | - Ovidiu Gabriel Bratu
- Department of Urology, Emergency Military Central Hospital, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania;
| | - Razvan Tiberiu Bardan
- Department of Urology, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (A.A.C.); (R.T.B.); (O.C.F.)
| | - Ovidiu Catalin Ferician
- Department of Urology, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (A.A.C.); (R.T.B.); (O.C.F.)
| | - Andrei Dragos Cumpanas
- Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Correspondence:
| | - Florin George Horhat
- Department of Microbiology, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (F.G.H.); (M.L.)
| | - Monica Licker
- Department of Microbiology, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (F.G.H.); (M.L.)
| | - Catalin Pricop
- Department of Urology, Gr.Tr.Popa University of Medicine and Pharmacy, 700115 Iasi, Romania;
| | - Octavian Marius Cretu
- Department of Surgery, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania;
| |
Collapse
|
5
|
Drago L. Prevotella Copri and Microbiota in Rheumatoid Arthritis: Fully Convincing Evidence? J Clin Med 2019; 8:jcm8111837. [PMID: 31683983 PMCID: PMC6912755 DOI: 10.3390/jcm8111837] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2019] [Accepted: 10/22/2019] [Indexed: 02/07/2023] Open
Abstract
Gut microbiota regulates the host’s immune system. Microorganisms and their compounds can co-exist peacefully with the immune system and coordinate its function and regulation. Some microbial clusters may be harmful and others helpful in the respective negative or positive balance of the immune network. These insights have revealed important mechanisms for understanding and treating autoimmune and inflammatory diseases. This Editorial aims to clarify the role of specific genus of gut microbiota, such as Prevotella, in influencing the pathogenesis of Rheumatoid Arthritis (RA).
Collapse
Affiliation(s)
- Lorenzo Drago
- Laboratory of Clinical Microbiology & Microbiome Unit, Department of Biomedical Sciences for Health, "Invernizzi" Pediatric Clinical Research Center, University of Milan, 20133 Milan, Italy.
| |
Collapse
|